Maternal Height is an Independent Risk of Adverse Outcomes in Women with Gestational Diabetes Mellitus

Mengkai Du,Marie Parfaite Uwimana Muhuza,Yibo Tang,Yanmin Chen,Danqing Chen,Lixia Zhang,Zhaoxia Liang
DOI: https://doi.org/10.1007/s13300-023-01512-3
2023-01-01
Diabetes Therapy
Abstract:Maternal height has been shown to be associated with adverse outcomes in women with gestational diabetes mellitus (GDM). The aim of this study is to evaluate the association between maternal height and adverse outcomes stratified for gestational weight gain (GWG) and pre-pregnancy body mass index (BMI) in women with GDM. We conducted a retrospective study that included 2048 women diagnosed with GDM during 24–28 gestational weeks from July 1, 2017, to June 30, 2018, in Zhejiang Province, China. Demographic data, maternal characteristics and pregnancy complications were extracted from medical records. Maternal height was divided into three categories by tertiles. Chi-square was used to evaluate categorical data while one-way ANOVA was utilized to analyze continuous variables. The relationship between maternal height and adverse outcomes was examined using logistic regression. We found that shorter women had higher rates of low birth weight (LBW) (p = 0.003) and primary cesarean section (primary CS) (p < 0.001) while taller women had higher rates of abnormal neonatal ponderal index (p < 0.001), postpartum hemorrhage (p = 0.044) and macrosomia (p < 0.001). In taller women who had excess GWG, maternal height was positively associated with the risk of macrosomia (aOR 1.97, 95
What problem does this paper attempt to address?